[1]
2012. Clinical and prognostic value of the initial doubling time of prostate-specific antigen in prostate cancer patients. Voprosy onkologii. 58, 6 (Dec. 2012), 817–820. DOI:https://doi.org/10.37469/0507-3758-2012-58-6-817-820.